BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16010417)

  • 1. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
    Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H
    Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.
    Nakagawa Y; Kuranaga Y; Tahara T; Yamashita H; Shibata T; Nagasaka M; Funasaka K; Ohmiya N; Akao Y
    Cancer Sci; 2019 Aug; 110(8):2540-2548. PubMed ID: 31162779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissues.
    Tong M; Zheng W; Lu X; Ao L; Li X; Guan Q; Cai H; Li M; Yan H; Guo Y; Chi P; Guo Z
    Oncotarget; 2015 Dec; 6(38):41216-27. PubMed ID: 26515599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.
    Zhang H; Tang J; Li C; Kong J; Wang J; Wu Y; Xu E; Lai M
    Cancer Lett; 2015 Jan; 356(2 Pt B):781-90. PubMed ID: 25449431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
    Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
    Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical value of GML and the p53 gene as a predictor of chemosensitivity for colorectal cancer.
    Hashimoto Y; Ueda K; Minami K; Watatani M
    Int J Clin Oncol; 2001 Apr; 6(2):90-6. PubMed ID: 11706756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
    Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
    Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
    Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
    Karasawa H; Miura K; Fujibuchi W; Ishida K; Kaneko N; Kinouchi M; Okabe M; Ando T; Murata Y; Sasaki H; Takami K; Yamamura A; Shibata C; Sasaki I
    Cancer Sci; 2009 May; 100(5):903-13. PubMed ID: 19302291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.
    Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R
    Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Li T; Gao F; Zhang XP
    Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.